Clinical Comparison of COVID Waves 2–5. An Inpatient Retrospective Comparative Analysis From Karachi, Pakistan
By
Muneeba Ahsan Sayeed
Elisha Shalim
Shaiza Farman
Fizza Farooqui
Beenish Syed
Ishfaque Ahmed
Anika Iqbal
Aneel Kumar
Raniyah Akhter
Furkan Hyder
Hasan Ali Shah
Adeel Hussain
Sarwat Rasheed
Saba Afshan
Rizwana Salik Nukrich
Madiha Raza
Haseeb U Rehman
Abdul Razzaque Memon
Abdul Wahid Rajput
Muhammad Saeed Quraishy
February 7, 2025
Clinical Scorecard: Comparative Clinical Analysis of COVID-19 Waves 2 to 5: A Retrospective Study of Inpatient Data from Karachi, Pakistan
At a Glance
Category Detail
Condition COVID-19 infection caused by SARS-CoV-2
Key Mechanisms SARS-CoV-2 binds to ACE2 receptors in various organs; different variants (Beta, B.1.1.7, Delta, Omicron) influence disease severity and outcomes
Target Population Adult inpatients (>16 years) with PCR-confirmed COVID-19 admitted to a specialized infectious diseases hospital in Karachi, Pakistan
Care Setting Inpatient hospital setting at Sindh Infectious Diseases Hospital & Research Center
Key Highlights
Wave 2 had the highest discharge rate (81%) and lowest mortality (18.9%) among waves 2 to 5. Wave 4 (Delta variant) showed the highest disease severity with predominant severe COVID on admission (79.4%), highest intubation (27.1%), septic shock (24.3%), disease progression (50.8%), and mortality (42.5%). Wave 5 (Omicron variant) involved mostly elderly patients with mild disease (22.4%), high comorbidity prevalence (84.6%), and increased acute kidney injury (29.2%).
Guideline-Based Recommendations
Diagnosis
Confirm COVID-19 infection via nasopharyngeal/oropharyngeal swab PCR testing. Assess disease severity on admission to guide management.
Management
Implement supportive care tailored to disease severity, including oxygen therapy and mechanical ventilation as needed. Monitor and manage complications such as cytokine release syndrome, septic shock, and acute kidney injury. Vaccination rollout is critical to reduce severity and mortality.
Monitoring & Follow-up
Monitor for disease progression, especially in severe cases (notably in wave 4). Regularly assess for organ dysfunction including respiratory failure and acute kidney injury. Track clinical parameters to identify cytokine release syndrome.
Risks
Advanced age and presence of comorbidities increase risk of severe disease and complications. Emergence of more virulent variants (e.g., Delta) correlates with higher mortality and severity. Delayed or inadequate treatment may worsen outcomes.
Patient & Prescribing Data
Adult hospitalized COVID-19 patients in Karachi during waves 2 to 5
Mortality and severity varied by wave and variant; vaccination and emerging therapies contributed to improved survival post-wave 2.
Clinical Best Practices
Early identification and classification of disease severity on admission to optimize resource allocation. Close monitoring for cytokine release syndrome and septic shock, especially during waves with higher severity. Prioritize vaccination to reduce disease severity and mortality. Adapt clinical management protocols according to predominant circulating variant and observed clinical patterns.
References